These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10992619)

  • 1. Heparin-induced thrombocytopenia: how to manage it, how to avoid it.
    Caiola E
    Cleve Clin J Med; 2000 Sep; 67(9):621-4. PubMed ID: 10992619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia and its treatment.
    Warkentin TE
    J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S29-35. PubMed ID: 10859582
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
    Baumgärtel MW; Eichler P; Glöckner WM; Ranze O; Greinacher A
    Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium.
    Ranze O; Ranze P; Magnani HN; Greinacher A
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S130-3. PubMed ID: 10650852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.
    Rice L; Nguyen PH; Vann AR
    Postgrad Med; 2002 Sep; 112(3):85-9. PubMed ID: 12360660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia: pathophysiology and management.
    Mureebe L; Silver D
    Vasc Endovascular Surg; 2002; 36(3):163-70. PubMed ID: 12075381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current agents for the treatment of patients with heparin-induced thrombocytopenia.
    Warkentin TE
    Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heparin-induced thrombocytopenia].
    Depasse F; Samama MM
    Ann Biol Clin (Paris); 2000; 58(3):317-26. PubMed ID: 10846236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Am J Cardiovasc Drugs; 2001; 1(6):429-43. PubMed ID: 14728002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT; Elliott WG; Zia AA
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
    von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
    Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and development of heparin-induced thrombocytopenia. Biological and clinical aspects].
    Elalamy I; Page Y; Viallon A; Tardy B; Conard J; Helft G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):961-74. PubMed ID: 10907445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Warkentin TE; Greinacher A
    Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia in France, 1980-1998.
    Nguyen P; de Maistre E; Cornillet-Lefebvre P; Regnault V; Lecompte T
    Semin Thromb Hemost; 1999; 25 Suppl 1():9-15. PubMed ID: 10357146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia: laboratory diagnosis and management.
    Elalamy I; Lecrubier C; Horellou MH; Conard J; Samama MM
    Ann Med; 2000 Dec; 32 Suppl 1():60-7. PubMed ID: 11209984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.